BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29311123)

  • 1. The Gut Microbiome and Multiple Sclerosis.
    Ochoa-Repáraz J; Kirby TO; Kasper LH
    Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 29311123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
    Mowry EM; Glenn JD
    Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin: A mediator of the gut-brain axis in multiple sclerosis.
    Malinova TS; Dijkstra CD; de Vries HE
    Mult Scler; 2018 Aug; 24(9):1144-1150. PubMed ID: 29117778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nerves to Conduct a Multiple Sclerosis Crime Investigation.
    Chopra S; Myers Z; Sekhon H; Dufour A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome and microbial translocation in multiple sclerosis.
    Mirza A; Mao-Draayer Y
    Clin Immunol; 2017 Oct; 183():213-224. PubMed ID: 28286112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".
    Pröbstel AK; Baranzini SE
    Neurotherapeutics; 2018 Jan; 15(1):126-134. PubMed ID: 29147991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the gut to treat multiple sclerosis.
    Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
    Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
    Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle.
    Elsayed NS; Aston P; Bayanagari VR; Shukla SK
    Front Immunol; 2022; 13():972160. PubMed ID: 36045671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
    Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process.
    Mestre L; Carrillo-Salinas FJ; Feliú A; Mecha M; Alonso G; Espejo C; Calvo-Barreiro L; Luque-García JL; Estevez H; Villar LM; Guaza C
    Gut Microbes; 2020 Nov; 12(1):1813532. PubMed ID: 32900255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
    Ochoa-Repáraz J; Kasper LH
    Transl Res; 2017 Jan; 179():126-138. PubMed ID: 27519147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
    Camara-Lemarroy CR; Metz LM; Yong VW
    World J Gastroenterol; 2018 Oct; 24(37):4217-4223. PubMed ID: 30310254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model.
    Hoffman K; Brownell Z; Doyle WJ; Ochoa-Repáraz J
    J Autoimmun; 2023 May; 137():102957. PubMed ID: 36435700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiome in neurological disorders.
    Cryan JF; O'Riordan KJ; Sandhu K; Peterson V; Dinan TG
    Lancet Neurol; 2020 Feb; 19(2):179-194. PubMed ID: 31753762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second brain: The connection between gut microbiota composition and multiple sclerosis.
    Farshbafnadi M; Agah E; Rezaei N
    J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.